Actively Recruiting

Age: 18Years +
All Genders
NCT07011914

Care in Multiple Sclerosis (MS)

Led by NYU Langone Health · Updated on 2026-05-05

300

Participants Needed

6

Research Sites

192 weeks

Total Duration

On this page

Sponsors

N

NYU Langone Health

Lead Sponsor

N

National Institute of Neurological Disorders and Stroke (NINDS)

Collaborating Sponsor

AI-Summary

What this Trial Is About

This study is structured around three main aims. In Aim 1, investigators will conduct community-based participatory research (CBPR) to develop culturally tailored methods to assess childhood adversity in multiple sclerosis (MS). Aim 2 will investigate the impact of childhood adversity on MS outcomes among individuals with relapsing-remitting MS (RRMS), among whom 70% belong to a group historically under-represented in MS research: Black, Hispanic, or poverty-impacted. Aim 2 procedures involve two visits that include a research blood draw and an MRI scan. In Aim 3, investigators will conduct interviews and surveys to explore environmental and social factors affecting quality of life for minority MS patients.

CONDITIONS

Official Title

Care in Multiple Sclerosis (MS)

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 to 29 years
  • Diagnosed with relapsing-remitting multiple sclerosis (RRMS) meeting international criteria
  • 70% of participants must self-identify as Black, Hispanic, or poverty-impacted (up to 138% of the federal poverty level)
  • Fluent in English or Spanish
  • For Aim 2: pediatric-onset MS (onset before age 18, enrollment age 18-25) or adult-onset MS (onset at 18 or older, enrollment age 19-29)
  • Disease duration less than 8 years
  • For Aim 3: completed at least 80% of Aim 2 study data
  • For Aim 3: interviews split evenly between participants with high and low PROMIS-10 scores
Not Eligible

You will not qualify if you...

  • Diagnosis of primary or secondary progressive MS
  • Unable to provide consent
  • MS relapse within 30 days before study entry
  • Presence of other major neurological or psychiatric illness

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 6 locations

1

University of Alabama at Birmingham

Birmingham, Alabama, United States, 35294

Actively Recruiting

2

University of California, San Francisco

San Francisco, California, United States, 94158

Actively Recruiting

3

University of Colorado Denver

Aurora, Colorado, United States, 80045

Actively Recruiting

4

Massachusetts General Hospital

Boston, Massachusetts, United States, 02114

Actively Recruiting

5

Cleveland Clinic

Cleveland, Ohio, United States, 44195

Actively Recruiting

6

Baylor College of Medicine

Houston, Texas, United States, 77030

Actively Recruiting

Loading map...

Research Team

T

Taj Adams

CONTACT

J

Josselyn Zavaka

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

3

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Care in Multiple Sclerosis (MS) | DecenTrialz